Baxter Healthcare Corporation: Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx on
Read the official notice at FDA (drug) →
Get alerts for Baxter Healthcare
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Baxter Healthcare Corporation
- Product
- Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12.
- Reason / hazard
- CGMP Deviations
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- US Nationwide; Puerto Rico; and Chile.
- Recall initiated
- 2026-08-06
- Code info
- Lot # NC188654, Exp Date: 08/31/2027; Lot # NC188821, Exp Date: 09/30/2027; Lot # NC193658, NC193702, Exp Date: 01/31/2028.
- Product quantity
- N/A
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Deerfield
- State
- IL
- Country
- United States
- Event id
- 99500
Free daily digest + "My products" watchlist